Compare Abbott Laboratories (ABT) vs iShares MSCI Hong Kong ETF (EWH) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
Abbott Laboratories vs iShares MSCI Hong Kong ETF — how do they compare? Abbott Laboratories trades at $95.59 (market cap $166.94B), while iShares MSCI Hong Kong ETF trades at $21.09. The key difference: Abbott Laboratories pays a 2.63% dividend while iShares MSCI Hong Kong ETF pays none. Which is the better fit depends on your goals.
| ABT | EWH | |
|---|---|---|
Market Cap | $166.94B | — |
Sector | Health | Broad Market / Factor |
52-Week High | $136.62 | $24.55 |
52-Week Low | $82.57 | $19.91 |
Enterprise Value | $193.69B | — |
Dividend Yield | 2.63% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Abbott Laboratories (ABT) trades at $95.63, up 0.25% on the day, with a bullish technical signal from moving averages and strong analyst support. The stock shows solid fundamentals with a P/E of 26.79 and net income margin of 13.91%, though recent earnings have been mixed. Recent news highlights regulatory approvals for new medical devices, supporting growth prospects.
The outlook remains positive with a consensus price target of $122.55, implying significant upside. Key risks include competitive pressures and macroeconomic headwinds, but strong institutional backing and consistent dividend payments provide stability for long-term investors.
EWH trades at $21.23, up 1.43% over the past 24 hours, with technical indicators showing a bearish trend from moving averages but neutral oscillators. The stock faces resistance and support clustered around $21, indicating consolidation. Recent corporate actions include a $0.35 dividend scheduled for June 2026. Market sentiment is influenced by Hong Kong's evolving role as a financial hub and regional economic developments.
Outlook remains cautious due to bearish technical signals and limited fundamental data visibility. Investment opportunities hinge on Hong Kong's economic resilience and IPO market growth, while risks include regulatory scrutiny and geopolitical tensions affecting Asian markets. Investors should await clearer financial metrics for a comprehensive assessment.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Abbott Laboratories
Abbott manufactures and markets medical devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, molecular diagnostic platforms, and immunoassays and point-of-care diagnostic equipment. Abbott derives approximately 60% of sales outside the United States.
Read more on ABT →About iShares MSCI Hong Kong ETF
EWH tracks the MSCI Hong Kong 25/50 Index, providing broad exposure to large and mid-cap companies listed in Hong Kong. It focuses on the established pillars of the local economy, with heavy weightings in financials, real estate, and utilities, serving as a single-country diversification tool.
Read more on EWH →
